MetaStat Inc

NEW
OTCPK:MTST (USA)  
$ 0.0010 (0%) 10:08 PM EST
At Loss
Market Cap:
$ 6.00K
Enterprise V:
$ 6.00K
Volume:
0
Avg Vol (2M):
222.00
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
222.00

Business Description

Description
MetaStat Inc is a us-based biotechnology company which focuses on discovering and developing personalized therapeutic (Rx) and diagnostic (Dx) treatment solutions for cancer patients. The company focuses on development programs of the novel therapeutic product candidates that target the Mena protein isoform whereas the Companion Diagnostics program is focused on developing companion tests to be used in combination with cancer drugs, that provide essential information for the safe and effective use of a corresponding drug or biological product to improve patient outcome. It also develops a prognostic diagnostic program which is focused on developing diagnostic tests that predict the risk of future metastasis in cancer patients following the initial treatment of their primary tumor.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
100
9-Day RSI
100
14-Day RSI
99.98
3-1 Month Momentum %
66.67
6-1 Month Momentum %
42.86
12-1 Month Momentum %
400

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin %
-11930.43
OCF Margin %
-11930.43

GF Value Rank

Name Current Vs Industry Vs History

GF Valueâ„¢

MetaStat Inc Filings

Filing Date Document Date Form
No Filing Data

MetaStat Inc Stock Events

Financials Calendars
Event Date Price ($)
0.066667:1 Stock Split 2015-10-08 4.65 (-3.13%)
0.1:1 Stock Split 2011-01-20 225.00 (+0.00%)
Show
Entries

Guru Commentaries on OTCPK:MTST

No articles.

Press Release

Subject Date
No Press Release

Articles on MetaStat Inc

No articles.

Headlines

See More
  • 1
No news.
  • 1